Medication Adherence With Telehealthcare Medication Therapy Management

NCT03978936 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 321

Last updated 2026-01-15

No results posted yet for this study

Summary

Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH) is a multi-center, randomized parallel group study targeted to an at-risk population of Adolescents and Young Adults (AYA) with uncontrolled asthma who have poor adherence with prescribed Inhaled corticosteroid (ICS) therapy.

Conditions

Interventions

BEHAVIORAL

Medication Therapy Management (MTM) Video Telehealthcare

MTM is an individualized approach to "optimize medication use for improved patient outcomes" and is designed to "empower patients to take an active role in managing patients' medications" thus, providing a favorable strategy for addressing adherence issues. Five core elements define MTM: complete medication therapy review (CMR), creation of a personal medication list (PML), development of a medication action plan (MAP), intervention and/or referral for drug therapy problems, and documentation and follow-up

BEHAVIORAL

Electronic Adherence Self-Management (EAM)

Participants will have a sensor which monitors their adherence to medication use

Sponsors & Collaborators

  • Nemours Children's Health System

    collaborator OTHER
  • American Lung Association

    collaborator OTHER
  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Kathryn Blake, Pharm.D · Nemours Children's Specialty Care

  • Robert Wise, MD · Johns Hopkins School of Medicine

  • Janet Holbrook, PhD · Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-18
Primary Completion
2025-03-14
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03978936 on ClinicalTrials.gov